Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
107.53 USD
0.63%
Market Closed
Updated:
Apr 27, 2024
Balance Sheet
Balance Sheet Decomposition
Abbott Laboratories
Abbott Laboratories
| Current Assets | 22.7B |
| Cash & Short-Term Investments | 7.3B |
| Receivables | 6.6B |
| Other Current Assets | 8.8B |
| Non-Current Assets | 50.5B |
| Long-Term Investments | 799m |
| PP&E | 10.2B |
| Intangibles | 32.5B |
| Other Non-Current Assets | 7.1B |
| Current Liabilities | 13.8B |
| Accounts Payable | 4.3B |
| Accrued Liabilities | 7B |
| Other Current Liabilities | 2.5B |
| Non-Current Liabilities | 20.8B |
| Long-Term Debt | 13.6B |
| Other Non-Current Liabilities | 7.2B |
Balance Sheet
Abbott Laboratories
Abbott Laboratories
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
4 063
|
5 001
|
18 620
|
9 407
|
3 844
|
3 860
|
6 838
|
9 799
|
9 882
|
6 896
|
|
| Cash Equivalents |
4 063
|
5 001
|
18 620
|
9 407
|
3 844
|
3 860
|
6 838
|
9 799
|
9 882
|
6 896
|
|
| Short-Term Investments |
397
|
1 124
|
155
|
203
|
242
|
280
|
310
|
450
|
288
|
383
|
|
| Total Receivables |
3 586
|
3 418
|
3 248
|
5 249
|
5 182
|
5 425
|
6 414
|
6 487
|
6 218
|
6 565
|
|
| Accounts Receivables |
3 586
|
3 418
|
3 248
|
5 249
|
5 182
|
5 425
|
6 414
|
6 487
|
6 218
|
6 565
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2 643
|
2 599
|
2 434
|
3 601
|
3 796
|
4 316
|
5 012
|
5 157
|
6 173
|
6 570
|
|
| Other Current Assets |
2 867
|
2 013
|
2 319
|
1 687
|
1 568
|
1 786
|
1 867
|
2 346
|
2 663
|
2 256
|
|
| Total Current Assets |
13 556
|
14 155
|
26 776
|
20 147
|
14 632
|
15 667
|
20 441
|
24 239
|
25 224
|
22 670
|
|
| PP&E Net |
5 935
|
5 730
|
5 705
|
7 607
|
7 563
|
8 972
|
10 130
|
10 112
|
10 278
|
11 276
|
|
| PP&E Gross |
5 935
|
5 730
|
5 705
|
7 607
|
7 563
|
8 972
|
10 130
|
10 112
|
10 278
|
11 276
|
|
| Accumulated Depreciation |
6 697
|
6 653
|
6 661
|
7 658
|
8 143
|
8 761
|
9 764
|
10 405
|
11 050
|
11 779
|
|
| Intangible Assets |
6 198
|
5 562
|
4 539
|
21 473
|
18 942
|
17 025
|
14 784
|
12 739
|
10 454
|
8 815
|
|
| Goodwill |
10 067
|
9 638
|
7 683
|
24 020
|
23 254
|
23 195
|
23 744
|
23 231
|
22 799
|
23 679
|
|
| Long-Term Investments |
229
|
4 041
|
2 947
|
883
|
897
|
883
|
821
|
816
|
766
|
799
|
|
| Other Long-Term Assets |
5 222
|
2 121
|
5 016
|
2 120
|
1 885
|
2 145
|
2 628
|
4 059
|
4 917
|
5 975
|
|
| Other Assets |
10 067
|
9 638
|
7 683
|
24 020
|
23 254
|
23 195
|
23 744
|
23 231
|
22 799
|
23 679
|
|
| Total Assets |
41 207
N/A
|
41 247
+0%
|
52 666
+28%
|
76 250
+45%
|
67 173
-12%
|
67 887
+1%
|
72 548
+7%
|
75 196
+4%
|
74 438
-1%
|
73 214
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 064
|
1 081
|
1 178
|
2 402
|
2 975
|
3 252
|
3 946
|
4 408
|
4 607
|
4 295
|
|
| Accrued Liabilities |
3 654
|
3 771
|
3 251
|
4 793
|
4 867
|
5 183
|
6 581
|
6 806
|
7 401
|
7 019
|
|
| Short-Term Debt |
3 937
|
2 688
|
868
|
206
|
200
|
201
|
213
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
55
|
3
|
3
|
508
|
7
|
1 277
|
7
|
754
|
2 251
|
1 080
|
|
| Other Current Liabilities |
1 757
|
1 643
|
1 360
|
1 003
|
963
|
950
|
1 160
|
1 137
|
1 230
|
1 447
|
|
| Total Current Liabilities |
10 467
|
9 186
|
6 660
|
8 912
|
9 012
|
10 863
|
11 907
|
13 105
|
15 489
|
13 841
|
|
| Long-Term Debt |
3 393
|
5 871
|
20 681
|
27 210
|
19 359
|
16 115
|
18 527
|
17 296
|
14 522
|
13 599
|
|
| Deferred Income Tax |
872
|
808
|
356
|
2 006
|
2 056
|
1 546
|
1 406
|
1 392
|
991
|
568
|
|
| Minority Interest |
113
|
115
|
179
|
201
|
198
|
213
|
219
|
222
|
219
|
224
|
|
| Other Liabilities |
4 836
|
4 056
|
4 252
|
7 024
|
6 024
|
8 062
|
7 705
|
7 379
|
6 531
|
6 379
|
|
| Total Liabilities |
19 681
N/A
|
20 036
+2%
|
32 128
+60%
|
45 353
+41%
|
36 649
-19%
|
36 799
+0%
|
39 764
+8%
|
39 394
-1%
|
37 752
-4%
|
34 611
-8%
|
|
| Equity | |||||||||||
| Common Stock |
12 383
|
12 734
|
13 027
|
23 206
|
23 512
|
23 853
|
24 145
|
24 470
|
24 709
|
24 869
|
|
| Retained Earnings |
22 874
|
25 757
|
25 565
|
23 978
|
24 560
|
25 847
|
27 627
|
31 528
|
35 257
|
37 554
|
|
| Unrealized Security Profit/Loss |
1
|
65
|
69
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
8 678
|
10 622
|
10 791
|
10 225
|
9 962
|
10 147
|
10 042
|
11 822
|
15 229
|
15 981
|
|
| Other Equity |
5 054
|
6 723
|
7 194
|
6 057
|
7 586
|
8 465
|
8 946
|
8 374
|
8 051
|
7 839
|
|
| Total Equity |
21 526
N/A
|
21 211
-1%
|
20 538
-3%
|
30 897
+50%
|
30 524
-1%
|
31 088
+2%
|
32 784
+5%
|
35 802
+9%
|
36 686
+2%
|
38 603
+5%
|
|
| Total Liabilities & Equity |
41 207
N/A
|
41 247
+0%
|
52 666
+28%
|
76 250
+45%
|
67 173
-12%
|
67 887
+1%
|
72 548
+7%
|
75 196
+4%
|
74 438
-1%
|
73 214
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 515
|
1 473
|
1 473
|
1 744
|
1 756
|
1 763
|
1 771
|
1 764
|
1 738
|
1 734
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
